0 2

Cited 0 times in

Foritinib, a type II ROS1 inhibitor for NSCLC

Authors
 Jii Bum Lee  ;  Sai-Hong Ignatius Ou 
Citation
 LANCET RESPIRATORY MEDICINE, Vol.12(9) : 656-657, 2024-09 
Journal Title
LANCET RESPIRATORY MEDICINE
ISSN
 2213-2600 
Issue Date
2024-09
MeSH
Antineoplastic Agents / therapeutic use ; Carcinoma, Non-Small-Cell Lung* / drug therapy ; Carcinoma, Non-Small-Cell Lung* / genetics ; Humans ; Lung Neoplasms* / drug therapy ; Lung Neoplasms* / genetics ; Protein Kinase Inhibitors / therapeutic use ; Protein-Tyrosine Kinases* / antagonists & inhibitors ; Proto-Oncogene Proteins* / genetics
Full Text
https://www.clinicalkey.com/#!/content/playContent/1-s2.0-S2213260024002108
DOI
10.1016/S2213-2600(24)00210-8
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
Yonsei Authors
Lee, Jii Bum(이기쁨) ORCID logo https://orcid.org/0000-0001-5608-3157
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/206525
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links